18F-FSPG PET/CT for Cancer Patients on Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: B-Cell Neoplasm|Estrogen Receptor Negative|HER2/Neu Negative|Metastatic Renal Cell Cancer|Progesterone Receptor Negative|Stage III Mesothelioma|Stage III Renal Cell Cancer|Stage IIIA Breast Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage IV Mesothelioma|Stage IV Non-Small Cell Lung Cancer|Stage IV Renal Cell Cancer|Triple-Negative Breast Carcinoma
Interventions: DRUG: 18F-FSPG|DRUG: 18F-FDG
Sponsor: Andrei Iagaru
Collaborators: National Cancer Institute (NCI)